>
Radian Single Stage to Orbit Space Plane
Wednesday War Room LIVE: Trump Reveals New Information on Assassination Attempts:
DARPA's high-speed VTOL X-plane passes ground effect testing
Smart stitches generate electricity on movement for faster healing
Jeff Bezos's Blue Origin Could Have a Commercial Space Station Running by 2030
Toyota Just Invested $500 Million in Electric Air-Taxi Maker Joby
Cheap, powerful, high-density EV battery cells set for mass production
World's first 3D-printed hotel rises in the Texas desert
Venus Aerospace Unveils Potential Mach 6 Hypersonic Engine and Will Power a Drone in 2025
OpenAI As We Knew It Is Dead, Now It's A Loose Cannon In The Hands Of A Megalomaniac Technocrat
Geothermal Energy Could Outperform Nuclear Power
I Learned How to Fly This Electric Aircraft in a Week--and I Didn't Need a License
"I am Exposing the Whole Damn Thing!" (MIND BLOWING!!!!) | Randall Carlson
Israel develops method for hacking air-gapped computers - no computer is safe now
After hearing about quality control lapses at a Moderna COVID-19 vaccine manufacturing facility, ICAN's legal team immediately sent FOIA requests to FDA for more details. ICAN has now obtained FDA's inspection report, which includes detailed descriptions about the conditions at the plant. In addition, ICAN submitted follow-up requests to dig even deeper.
Lead Counsel, Aaron Siri, Esq. details the shocking new information here:
On December 15, 2023, news broke that FDA found numerous quality control lapses during its September 11 to September 21, 2023 inspection of Moderna's Norwood, Massachusetts facility, where it manufacturers its COVID-19 vaccine.
ICAN's attorneys immediately submitted several FOIA requests to get more details on the inspection's findings. In response, FDA recently produced this report to ICAN which has some stunning findings, including air and temperature alarms that were ignored, use of expired materials in the mRNA vaccines, failure to collect cleaning verification samples, and failure to design and control air handling equipment to reduce potential for contamination.
Incredibly, the report notes that Moderna "does not ensure that the equipment used for drug substance manufacturing are appropriately cleaned prior to the manufacturing of mRNA-1273 drug substance" and then proceeds to list the drug substance batch numbers that were manufactured using equipment utilized "without confirming the cleaning verifications test results for bioburden and endotoxin prior to the usage for subsequent batch manufacturing."